Kovai Medical

Why is Kovai Medical Center & Hospital Ltd falling/rising?

As of 07-Jul, Kovai Medical Center & Hospital Ltd's stock price is rising, currently at 6,015.85, with a strong performance over the past month (+11.86%) and positive financial metrics, including a high ROCE of 20.78% and low debt to EBITDA ratio of 0.96. Despite a decline in investor participation, the stock remains liquid and is trading at a discount compared to peers, contributing to its upward trend.

As of 07-Jul, Kovai Medical Center & Hospital Ltd's stock price is rising, currently at 6,015.85, reflecting a change of 2.75 (0.05%) upwards. The stock has shown strong performance over the past month, with a return of +11.86%, significantly outperforming the benchmark Sensex, which gained +5.30% in the same period. Additionally, the stock has been trading above its moving averages across various time frames, indicating a positive trend.<BR><BR>Despite a recent decline in investor participation, with delivery volume falling by 43.07% against the 5-day average, the stock remains liquid enough for trading. The company's financial metrics also support its rising price; it boasts a high return on capital employed (ROCE) of 20.78% and a low debt to EBITDA ratio of 0.96 times, showcasing its strong ability to service debt. Furthermore, the stock is trading at a discount compared to its peers' average historical valuations, which adds to its attractiveness.<BR><BR>Overall, the combination of solid financial performance, positive stock movement relative to benchmarks, and favorable valuation metrics contributes to the rising price of Kovai Medical Center & Hospital Ltd.

Which are the latest news on Kovai Medical?

How big is Kovai Medical?

As of 10th June, Kovai Medical Center & Hospital Ltd has a market capitalization of 6,403.00 Cr, with recent net sales of 1,584.15 Cr and net profit of 244.46 Cr over the last four quarters.

As of 10th June, <BR><BR>Market Cap: Kovai Medical Center & Hospital Ltd has a market capitalization of 6,403.00 Cr, categorizing it as a Small Cap company.<BR><BR>Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 1,584.15 Cr, while the sum of Net Profit for the same period is 244.46 Cr.<BR><BR>Balance Sheet Snapshot: The latest reporting period is March 2018, with Shareholder's Funds amounting to 288.56 Cr and Total Assets valued at 606.12 Cr.

Who are in the management team of Kovai Medical?

The management team of Kovai Medical includes key members such as Nalla G Palaniswami (Managing Director), Thavamani Devi Palaniswami (Joint Managing Director), and several independent directors. They oversee the company's governance and operations.

The management team of Kovai Medical includes the following key members:<BR><BR>1. **Nalla G Palaniswami** - Managing Director<BR>2. **Thavamani Devi Palaniswami** - Joint Managing Director<BR>3. **Arun N Palaniswami** - Whole-time Director<BR>4. **Kasi K Goundan** - Independent Director<BR>5. **M Manickam** - Independent Director<BR>6. **A M Palanisamy** - Independent Director<BR>7. **M C Thirumoorthi** - Director<BR>8. **K Saminathan** - Independent Director<BR>9. **Purani P Palaniswami** - Director<BR>10. **Mohan S Gounder** - Director<BR>11. **R Bhuvaneshwari** - Independent Director<BR>12. **A P Ammasai Kutty** - Independent Director<BR>13. **K. Kolandaswamy** - Independent Director<BR>14. **R Ponmanikandan** - Company Secretary & Compliance Officer<BR><BR>This team plays a crucial role in the governance and operational management of the company.

Who are the peers of the Kovai Medical?

Kovai Medical's peers include Health.Global, Jupiter Life Lin, Yatharth Hospital, Jeena Sikho, Artemis Medicare, Indraprastha Medical, Dr. Agarwal's Eye, KMC Specialty, and Shalby. Kovai Medical has good management risk and average growth, with a 1-year return of -3.11%, compared to peers with varying management risks and returns.

Peers: The peers of Kovai Medical are Health.Global, Jupiter Life Lin, Yatharth Hospit., Jeena Sikho, Artemis Medicare, Indrapr.Medical, Dr Agarwal's Eye, KMC Speciality, and Shalby.<BR><BR>Quality Snapshot: Excellent management risk is observed at Jupiter Life Lin and Yatharth Hospit., while Good management risk is found at Kovai Medical. Average management risk is noted at Health.Global, Artemis Medicare, Indrapr.Medical, Dr Agarwal's Eye, KMC Speciality, Shalby, and the rest. For growth, Excellent growth is seen at Health.Global, Jeena Sikho, and Artemis Medicare, while Average growth is noted at Kovai Medical, and Good growth is found at Yatharth Hospit., Indrapr.Medical, KMC Speciality, and the rest. In terms of Capital Structure, Excellent capital structure is observed at Jupiter Life Lin, Yatharth Hospit., Jeena Sikho, Indrapr.Medical, and KMC Speciality, while Good capital structure is noted at Kovai Medical and Artemis Medicare, and Below Average capital structure is found at Health.Global.<BR><BR>Return Snapshot: KMC Speciality has the highest 1-year return at 76.11%, while Jupiter Life Lin has the lowest at -13.75%. Kovai Medical's 1-year return is -3.11%, which is higher than Jupiter Life Lin's but lower than KMC Speciality's. Additionally, several peers, including Health.Global, Artemis Medicare, Indrapr.Medical, and Shalby, have negative six-month returns.

What does Kovai Medical do?

Kovai Medical Center and Hospital Ltd is a multi-specialty hospital in Coimbatore, established in 1990, with a capacity of 200 beds and satellite centers in Coimbatore and Erode. As of March 2026, it reported net sales of 413 Cr and a net profit of 63 Cr, with a market cap of INR 6,403 Cr.

Overview:<BR>Kovai Medical Center and Hospital Ltd operates as a multi-specialty hospital in the healthcare industry, categorized as a small-cap company.<BR><BR>History:<BR>The company was incorporated in 1985 and began its hospital operations in 1990 with a flagship multi-specialty hospital in Coimbatore, featuring a capacity of 200 beds. It has since established satellite centers in Coimbatore and Erode. The latest reported quarterly results for net sales and profit are for March 2026.<BR><BR>Financial Snapshot:<BR>Net Sales: 413 Cr (Quarterly Results - Mar 2026) <BR>Net Profit: 63 Cr (Quarterly Results - Mar 2026) <BR>Market Cap: INR 6,403 Cr (Small Cap)<BR><BR>Key Metrics:<BR>P/E: 26.00 <BR>Industry P/E: 60 <BR>Dividend Yield: 0.17% <BR>Debt-Equity: 0.08 <BR>Return on Equity: 20.54% <BR>Price to Book: 5.29 <BR><BR>Contact Details:<BR>Address: 99 Avanashi Road, Coimbatore Tamil Nadu: 641014 <BR>Tel: 91-422-4323800/3083800 <BR>Email: secretarialdept@kmchhospitals.com <BR>Website: http://www.kmchhospitals.com

Should I buy, sell or hold Kovai Medical Center & Hospital Ltd?

Are Kovai Medical Center & Hospital Ltd latest results good or bad?

Kovai Medical Center & Hospital Ltd's latest results show strong revenue growth with ₹413.20 crores in Q4 FY26, up 15.86% year-on-year, but net profit declined by 8.20% quarter-on-quarter to ₹59.69 crores, indicating operational challenges and margin compression that investors should watch closely.

Kovai Medical Center & Hospital Ltd's latest results present a mixed picture. In Q4 FY26, the company achieved a record revenue of ₹413.20 crores, reflecting a 1.62% increase quarter-on-quarter and a significant 15.86% growth year-on-year. This indicates strong patient volumes and effective market positioning in Tamil Nadu's healthcare sector.<BR><BR>However, the net profit for the same quarter was ₹59.69 crores, which represents an 8.20% decline compared to the previous quarter, although it shows a 9.12% increase year-on-year. The profitability margins have also contracted, with the operating margin decreasing to 26.86% from 28.52% in the prior quarter, and the PAT margin dropping to 14.45% from 15.99%. This decline in margins raises concerns about operational efficiency and cost management, particularly due to rising employee costs.<BR><BR>Overall, while the revenue growth is commendable, the significant drop in net profit and margin compression suggest that the company is facing operational challenges that need to be addressed. Investors should monitor these trends closely to gauge the company's future performance.

Is Kovai Medical technically bullish or bearish?

As of December 3, 2025, Kovai Medical's trend has shifted to mildly bearish, supported by bearish signals from the MACD, KST, and Dow Theory, despite some mildly bullish indications from daily moving averages.

As of 3 December 2025, the technical trend for Kovai Medical has changed from mildly bullish to mildly bearish. The current stance is mildly bearish, driven by the weekly and monthly MACD and KST indicators, both indicating a bearish outlook. The Dow Theory also supports this bearish sentiment on both weekly and monthly time frames. While the daily moving averages show a mildly bullish signal, the overall trend is overshadowed by the bearish signals from the weekly Bollinger Bands and the lack of strong signals from the RSI. The recent price action reflects a decline from the previous close, further confirming the bearish trend.

How has been the historical performance of Kovai Medical?

Kovai Medical's historical performance from March 2013 to March 2018 shows strong growth in net sales from 297.01 Cr to 585.51 Cr, with total operating income reaching 592.37 Cr and profit after tax at 57.98 Cr. Despite rising expenditures and total liabilities of 606.12 Cr, the company maintained positive cash flow and a solid earnings per share of 52.99.

Answer:<BR>The historical performance of Kovai Medical shows a consistent growth trajectory in net sales, with figures rising from 297.01 Cr in March 2013 to 585.51 Cr in March 2018. Other operating income also increased, albeit from a negligible amount in earlier years to 6.85 Cr by March 2018. Total operating income followed a similar upward trend, reaching 592.37 Cr in March 2018. The company's total expenditure, excluding depreciation, rose to 463.26 Cr in March 2018, reflecting increased operational costs. Operating profit, excluding other income, was 129.11 Cr in March 2018, with a slight decrease in the operating profit margin to 21.79%. Profit before tax peaked at 89.44 Cr in March 2018, while profit after tax was recorded at 57.98 Cr, showing a slight decline from the previous year. The earnings per share (EPS) was 52.99, with a book value per share of 263.71. On the balance sheet, total liabilities increased to 606.12 Cr, driven by long-term borrowings of 164.56 Cr. Total assets also grew to 606.12 Cr, with cash and cash equivalents at 23.68 Cr by March 2018, indicating a positive cash flow trend despite a significant outflow from investing activities.<BR><BR>Breakdown:<BR>Kovai Medical's financial performance from March 2013 to March 2018 illustrates robust growth in net sales, which increased from 297.01 Cr to 585.51 Cr, alongside a rise in other operating income to 6.85 Cr. Total operating income reached 592.37 Cr, while total expenditure climbed to 463.26 Cr, reflecting the company's expanding operations. Operating profit, excluding other income, was 129.11 Cr, with a slight decrease in the operating profit margin to 21.79%. Profit before tax was 89.44 Cr, and profit after tax was 57.98 Cr, indicating a minor decline from the previous year. The earnings per share stood at 52.99, and the book value per share increased to 263.71. On the balance sheet, total liabilities rose to 606.12 Cr, primarily due to long-term borrowings of 164.56 Cr, while total assets matched this figure, with cash and cash equivalents at 23.68 Cr, reflecting a positive cash flow despite significant investment outflows.

Is Kovai Medical overvalued or undervalued?

As of November 10, 2025, Kovai Medical is considered very attractive in valuation, with a PE ratio of 29.89, an EV to EBITDA of 16.66, and a ROE of 21.05%, significantly lower than peers like Max Healthcare and Apollo Hospitals, while also outperforming the Sensex with an 11.59% return compared to its 5.09%.

As of 10 November 2025, Kovai Medical has moved from an attractive to a very attractive valuation grade. The company appears to be undervalued based on its current metrics. Key ratios include a PE ratio of 29.89, an EV to EBITDA of 16.66, and a ROE of 21.05%. <BR><BR>In comparison to its peers, Kovai Medical's PE ratio is significantly lower than that of Max Healthcare, which stands at 88.71, and Apollo Hospitals at 64.78, indicating a more favorable valuation. The company's recent stock performance has outpaced the Sensex over the last year, returning 11.59% compared to the Sensex's 5.09%, reinforcing the attractiveness of its current valuation.

Who are the top shareholders of the Kovai Medical?

The top shareholders of Kovai Medical include Kovai Purani Finance Private Limited with 36.96%, individual investors with 22.47%, and various institutional investors holding a total of 4.95%. Notably, there are no pledged promoter holdings.

The top shareholders of Kovai Medical include a mix of promoters and public investors. The majority of the shares are held by promoters, with Kovai Purani Finance Private Limited being the largest shareholder, owning 36.96% of the company. Additionally, individual investors collectively hold 22.47% of the shares. <BR><BR>In terms of institutional investors, there are 6 mutual fund schemes that hold a total of 3.67%, and 61 foreign institutional investors (FIIs) hold 1.28%. The highest public shareholder is Dsp Healthcare Fund, which has a holding of 1.63%. There are no pledged promoter holdings reported.

When is the next results date for Kovai Medical?

No Upcoming Board Meetings

Has Kovai Medical declared dividend?

Kovai Medical Center & Hospital Ltd has declared a 100% dividend, amounting to ₹10 per share, with an ex-date of August 1, 2024. The company has shown strong total returns over various periods, with a 5-year total return of 839.69%.

Kovai Medical Center & Hospital Ltd has declared a 100% dividend.<BR><BR>Dividend Details:<BR>- Percentage announced: 100%<BR>- Amount per share: 10<BR>- Ex-date: 01 Aug 24<BR><BR>Dividend Yield: 0.16%.<BR><BR>Total Returns by Period:<BR>In the last 6 months, the price return was 13.86%, with a dividend return of 0%, resulting in a total return of 13.86%.<BR><BR>Over the past year, the price return was 42.66%, the dividend return was 0.23%, leading to a total return of 42.89%.<BR><BR>For the 2-year period, the price return was 168.15%, the dividend return was 0.68%, culminating in a total return of 168.83%.<BR><BR>In the 3-year period, the price return was 327.22%, with a dividend return of 1.30%, resulting in a total return of 328.52%.<BR><BR>Over the last 4 years, the price return was 312.75%, the dividend return was 1.56%, leading to a total return of 314.31%.<BR><BR>In the 5-year period, the price return was 836.48%, with a dividend return of 3.21%, resulting in a total return of 839.69%.<BR><BR>Overall, Kovai Medical has declared a substantial dividend while also demonstrating impressive total returns across various periods, indicating strong financial performance and shareholder value enhancement.